{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:40:04Z","timestamp":1749037204508,"version":"3.41.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22ek0610028h0001"],"award-info":[{"award-number":["22ek0610028h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004721","name":"University of Tokyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K08402"],"award-info":[{"award-number":["23K08402"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bbrep.2025.102025","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T12:55:37Z","timestamp":1745672137000},"page":"102025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metabolism of sphingolipids in a rat spinal cord stenosis model"],"prefix":"10.1016","volume":"42","author":[{"given":"Baasanjav","family":"Uranbileg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Ezaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kurano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanji","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Yatomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9581-3925","authenticated-orcid":false,"given":"Nobuko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bbrep.2025.102025_bib1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrneurol.2009.90","article-title":"Lumbar spinal stenosis: syndrome, diagnostics and treatment","volume":"5","author":"Siebert","year":"2009","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.bbrep.2025.102025_bib2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.spinee.2009.03.005","article-title":"Spinal stenosis prevalence and association with symptoms: the Framingham Study","volume":"9","author":"Kalichman","year":"2009","journal-title":"Spine J."},{"issue":"10","key":"10.1016\/j.bbrep.2025.102025_bib3","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.joca.2012.06.018","article-title":"Prevalence of symptomatic lumbar spinal stenosis and its association with physical performance in a population-based cohort in Japan: the Wakayama Spine Study","volume":"20","author":"Ishimoto","year":"2012","journal-title":"Osteoarthr. Cartil."},{"issue":"6","key":"10.1016\/j.bbrep.2025.102025_bib4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00776-013-0455-5","article-title":"Prevalence of lumbar spinal stenosis, using the diagnostic support tool, and correlated factors in Japan: a population-based study","volume":"18","author":"Yabuki","year":"2013","journal-title":"J. Orthop. Sci."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102025_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/metabo14010054","article-title":"Advances in mass spectrometry-based blood metabolomics profiling for non-cancer diseases: a comprehensive review","volume":"14","author":"Demicheva","year":"2024","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102025_bib6","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1038\/s41598-024-56321-w","article-title":"Development of an advanced liquid chromatography-tandem mass spectrometry measurement system for simultaneous sphingolipid analysis","volume":"14","author":"Uranbileg","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102025_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2217\/bmm.14.81","article-title":"Lipidomics applications for disease biomarker discovery in mammal models","volume":"9","author":"Zhao","year":"2015","journal-title":"Biomarkers Med."},{"issue":"21","key":"10.1016\/j.bbrep.2025.102025_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111358","article-title":"A lipidomics atlas of selected sphingolipids in multiple mouse nervous system regions","volume":"22","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102025_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbalip.2014.08.011","article-title":"Lipids in the nervous system: from biochemistry and molecular biology to patho-physiology","volume":"1851","author":"Cermenati","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrep.2025.102025_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1066578","article-title":"Modulations of bioactive lipids and their receptors in postmortem Alzheimer's disease brains","volume":"14","author":"Kurano","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbrep.2025.102025_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.prostaglandins.2016.12.002","article-title":"Recent advances in lipidomics: analytical and clinical perspectives","volume":"128\u2013129","author":"Sethi","year":"2017","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.bbrep.2025.102025_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2020.101079","article-title":"Pathogenic mechanisms of lipid mediator lysophosphatidic acid in chronic pain","volume":"81","author":"Ueda","year":"2021","journal-title":"Prog. Lipid Res."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102025_bib13","doi-asserted-by":"crossref","first-page":"9144","DOI":"10.1038\/s41598-019-45742-7","article-title":"Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis","volume":"9","author":"Hayakawa","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102025_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52999-5","article-title":"Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: a study using a rat cauda equina compression model","volume":"9","author":"Uranbileg","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102025_bib15","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1038\/s41598-021-83569-3","article-title":"Inhibition of autotaxin activity ameliorates neuropathic pain derived from lumbar spinal canal stenosis","volume":"11","author":"Uranbileg","year":"2021","journal-title":"Sci. Rep."},{"issue":"1\u20133","key":"10.1016\/j.bbrep.2025.102025_bib16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1388-1981(02)00139-7","article-title":"Signaling of sphingosine-1-phosphate via the S1P\/EDG-family of G-protein-coupled receptors","volume":"1582","author":"Kluk","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"1\u20133","key":"10.1016\/j.bbrep.2025.102025_bib17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1388-1981(02)00145-2","article-title":"Subtype-specific differential regulation of Rho family G proteins and cell migration by the Edg family sphingosine-1-phosphate receptors","volume":"1582","author":"Takuwa","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.bbrep.2025.102025_bib18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1043-6618(03)00046-X","article-title":"Signaling and biological actions of sphingosine 1-phosphate","volume":"47","author":"Hla","year":"2003","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.bbrep.2025.102025_bib19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1042\/BJ20111626","article-title":"Ceramide synthases at the centre of sphingolipid metabolism and biology","volume":"441","author":"Mullen","year":"2012","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102025_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bbrep.2025.102025_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrep.2025.102025_bib22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.chemphyslip.2018.09.013","article-title":"Visualizing bioactive ceramides","volume":"216","author":"Canals","year":"2018","journal-title":"Chem. Phys. Lipids"},{"issue":"6","key":"10.1016\/j.bbrep.2025.102025_bib23","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cellsig.2007.12.006","article-title":"The sphingolipid salvage pathway in ceramide metabolism and signaling","volume":"20","author":"Kitatani","year":"2008","journal-title":"Cell. Signal."},{"issue":"9","key":"10.1016\/j.bbrep.2025.102025_bib24","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1080\/14728222.2020.1787989","article-title":"The ceramide-S1P pathway as a druggable target to alleviate peripheral neuropathic pain","volume":"24","author":"Langeslag","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.bbrep.2025.102025_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tips.2012.12.001","article-title":"Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain","volume":"34","author":"Salvemini","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrep.2025.102025_bib26","article-title":"Dysregulation of sphingolipid metabolism in pain","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbrep.2025.102025_bib27","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1523\/JNEUROSCI.4479-12.2013","article-title":"Sphingosine-1-phosphate-induced nociceptor excitation and ongoing pain behavior in mice and humans is largely mediated by S1P3 receptor","volume":"33","author":"Camprub\u00ed-Robles","year":"2013","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.bbrep.2025.102025_bib28","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1096\/fj.10-178095","article-title":"Intraplantar-injected ceramide in rats induces hyperalgesia through an NF-\u03baB- and p38 kinase-dependent cyclooxygenase 2\/prostaglandin E2 pathway","volume":"25","author":"Doyle","year":"2011","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102025_bib29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbrc.2012.03.153","article-title":"The critical role of spinal ceramide in the development of partial sciatic nerve ligation-induced neuropathic pain in mice","volume":"421","author":"Kobayashi","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"21","key":"10.1016\/j.bbrep.2025.102025_bib30","doi-asserted-by":"crossref","first-page":"10557","DOI":"10.1073\/pnas.1820466116","article-title":"Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain","volume":"116","author":"Chen","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"5","key":"10.1016\/j.bbrep.2025.102025_bib31","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1084\/jem.20170584","article-title":"Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain","volume":"215","author":"Stockstill","year":"2018","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102025_bib32","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/jalm\/jfaa022","article-title":"Establishment of a measurement system for sphingolipids in the cerebrospinal fluid based on liquid chromatography-tandem mass spectrometry, and its application in the diagnosis of carcinomatous meningitis","volume":"5","author":"Sakai","year":"2020","journal-title":"J Appl Lab Med"},{"issue":"5","key":"10.1016\/j.bbrep.2025.102025_bib33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/iub.319","article-title":"Mammalian ceramide synthases","volume":"62","author":"Levy","year":"2010","journal-title":"IUBMB Life"},{"issue":"6463","key":"10.1016\/j.bbrep.2025.102025_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar5551","article-title":"Sphingosine 1-phosphate: lipid signaling in pathology and therapy","volume":"366","author":"Cartier","year":"2019","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bbrep.2025.102025_bib35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nri2974","article-title":"The outs and the ins of sphingosine-1-phosphate in immunity","volume":"11","author":"Spiegel","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.bbrep.2025.102025_bib36","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/glia.21021","article-title":"Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions","volume":"58","author":"Van Doorn","year":"2010","journal-title":"Glia"},{"issue":"11","key":"10.1016\/j.bbrep.2025.102025_bib37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.tips.2020.09.006","article-title":"Targeting the sphingosine-1-phosphate Axis for developing non-narcotic pain therapeutics","volume":"41","author":"Squillace","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrep.2025.102025_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2019.100670","article-title":"Sphingosine-1-phosphate signaling: a novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain","volume":"75","author":"Singh","year":"2020","journal-title":"Adv Biol Regul"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102025_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12974-017-0882-x","article-title":"Sphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes","volume":"14","author":"Dusaban","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102025_bib40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1634\/stemcells.2006-0223","article-title":"Essential roles of sphingosine 1-phosphate\/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury","volume":"25","author":"Kimura","year":"2007","journal-title":"Stem Cell."},{"issue":"26","key":"10.1016\/j.bbrep.2025.102025_bib41","doi-asserted-by":"crossref","first-page":"15983","DOI":"10.1073\/pnas.2237050100","article-title":"Migration and differentiation of neural precursor cells can be directed by microglia","volume":"100","author":"Aarum","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102025_bib42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pharmthera.2007.08.005","article-title":"Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis","volume":"117","author":"Dev","year":"2008","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.bbrep.2025.102025_bib43","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.2353\/ajpath.2010.091234","article-title":"Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices","volume":"176","author":"Miron","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102025_bib44","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1471-4159.2007.04629.x","article-title":"Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors","volume":"102","author":"Mullershausen","year":"2007","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.bbrep.2025.102025_bib45","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/jnc.14313","article-title":"Sphingosine 1-phosphate receptors regulate TLR4-induced CXCL5 release from astrocytes and microglia","volume":"144","author":"O'Sullivan","year":"2018","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.bbrep.2025.102025_bib46","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1074\/jbc.M707386200","article-title":"Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate","volume":"283","author":"Laviad","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102025_bib47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00418-007-0344-0","article-title":"Differential expression of (dihydro)ceramide synthases in mouse brain: oligodendrocyte-specific expression of CerS2\/Lass2","volume":"129","author":"Becker","year":"2008","journal-title":"Histochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102025_bib48","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.biocel.2011.12.019","article-title":"Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth","volume":"44","author":"Hartmann","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbrep.2025.102025_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/B978-0-12-394274-6.00002-9","article-title":"Diverse functions of ceramide in cancer cell death and proliferation","volume":"117","author":"Saddoughi","year":"2013","journal-title":"Adv. Cancer Res."},{"issue":"9","key":"10.1016\/j.bbrep.2025.102025_bib50","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/j.pain.0000000000001611","article-title":"NLRP2 inflammasome in dorsal root ganglion as a novel molecular platform that produces inflammatory pain hypersensitivity","volume":"160","author":"Matsuoka","year":"2019","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.bbrep.2025.102025_bib51","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1111\/j.1460-9568.2004.03750.x","article-title":"Caspase signalling in neuropathic and inflammatory pain in the rat","volume":"20","author":"Joseph","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102025_bib52","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.0022-3042.2001.00752.x","article-title":"Ceramide activates microglia to enhance the production\/secretion of brain-derived neurotrophic factor (BDNF) without induction of deleterious factors in vitro","volume":"80","author":"Nakajima","year":"2002","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.bbrep.2025.102025_bib53","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/jnc.14225","article-title":"Activation of the NLRP3 inflammasome in microglia: the role of ceramide","volume":"143","author":"Scheiblich","year":"2017","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102025_bib54","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1113\/jphysiol.2002.024265","article-title":"Ceramide, a putative second messenger for nerve growth factor, modulates the TTX-resistant Na(+) current and delayed rectifier K(+) current in rat sensory neurons","volume":"544","author":"Zhang","year":"2002","journal-title":"J. Physiol."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825001128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825001128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:16:54Z","timestamp":1749035814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580825001128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":54,"alternative-id":["S2405580825001128"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102025","relation":{},"ISSN":["2405-5808"],"issn-type":[{"type":"print","value":"2405-5808"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolism of sphingolipids in a rat spinal cord stenosis model","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102025"}}